nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—GRM5—GPCRs, Class C Metabotropic glutamate, pheromone—GRM7—attention deficit hyperactivity disorder	0.0731	0.123	CbGpPWpGaD
Rufinamide—GRM5—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM7—attention deficit hyperactivity disorder	0.0333	0.0562	CbGpPWpGaD
Rufinamide—GRM5—forebrain—attention deficit hyperactivity disorder	0.0254	0.0625	CbGeAlD
Rufinamide—SCN7A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0252	0.0426	CbGpPWpGaD
Rufinamide—SCN11A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0225	0.038	CbGpPWpGaD
Rufinamide—SCN8A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0206	0.0347	CbGpPWpGaD
Rufinamide—GRM5—midbrain—attention deficit hyperactivity disorder	0.0168	0.0413	CbGeAlD
Rufinamide—SCN9A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0166	0.0281	CbGpPWpGaD
Rufinamide—SCN3A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0159	0.0269	CbGpPWpGaD
Rufinamide—SCN2A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0153	0.0258	CbGpPWpGaD
Rufinamide—SCN4A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0153	0.0258	CbGpPWpGaD
Rufinamide—SCN1A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0148	0.0249	CbGpPWpGaD
Rufinamide—SCN10A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0148	0.0249	CbGpPWpGaD
Rufinamide—GRM5—Hypothetical Network for Drug Addiction—DRD1—attention deficit hyperactivity disorder	0.0147	0.0249	CbGpPWpGaD
Rufinamide—SCN8A—forebrain—attention deficit hyperactivity disorder	0.0143	0.0352	CbGeAlD
Rufinamide—GRM5—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.0139	0.0234	CbGpPWpGaD
Rufinamide—GRM5—nervous system—attention deficit hyperactivity disorder	0.0138	0.0339	CbGeAlD
Rufinamide—SCN7A—cardiovascular system—attention deficit hyperactivity disorder	0.0136	0.0334	CbGeAlD
Rufinamide—GRM5—central nervous system—attention deficit hyperactivity disorder	0.0133	0.0327	CbGeAlD
Rufinamide—GRM5—cerebellum—attention deficit hyperactivity disorder	0.013	0.0319	CbGeAlD
Rufinamide—GRM5—Hypothetical Network for Drug Addiction—DRD2—attention deficit hyperactivity disorder	0.0129	0.0218	CbGpPWpGaD
Rufinamide—SCN1A—forebrain—attention deficit hyperactivity disorder	0.0108	0.0266	CbGeAlD
Rufinamide—GRM5—brain—attention deficit hyperactivity disorder	0.0106	0.0259	CbGeAlD
Rufinamide—SCN5A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0104	0.0175	CbGpPWpGaD
Rufinamide—SCN11A—nervous system—attention deficit hyperactivity disorder	0.0102	0.0252	CbGeAlD
Rufinamide—CES1—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.01	0.0169	CbGpPWpGaD
Rufinamide—SCN2A—forebrain—attention deficit hyperactivity disorder	0.00993	0.0244	CbGeAlD
Rufinamide—SCN11A—central nervous system—attention deficit hyperactivity disorder	0.00987	0.0242	CbGeAlD
Rufinamide—SCN7A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00969	0.0163	CbGpPWpGaD
Rufinamide—SCN10A—forebrain—attention deficit hyperactivity disorder	0.00957	0.0235	CbGeAlD
Rufinamide—SCN3A—forebrain—attention deficit hyperactivity disorder	0.00873	0.0214	CbGeAlD
Rufinamide—SCN11A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00864	0.0146	CbGpPWpGaD
Rufinamide—CES1—cardiovascular system—attention deficit hyperactivity disorder	0.00847	0.0208	CbGeAlD
Rufinamide—SCN9A—midbrain—attention deficit hyperactivity disorder	0.0083	0.0204	CbGeAlD
Rufinamide—SCN8A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0079	0.0133	CbGpPWpGaD
Rufinamide—SCN11A—brain—attention deficit hyperactivity disorder	0.00783	0.0192	CbGeAlD
Rufinamide—SCN8A—nervous system—attention deficit hyperactivity disorder	0.00777	0.0191	CbGeAlD
Rufinamide—SCN8A—central nervous system—attention deficit hyperactivity disorder	0.00748	0.0184	CbGeAlD
Rufinamide—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.00736	0.0181	CbGeAlD
Rufinamide—SCN8A—cerebellum—attention deficit hyperactivity disorder	0.00731	0.018	CbGeAlD
Rufinamide—SCN1A—midbrain—attention deficit hyperactivity disorder	0.00714	0.0176	CbGeAlD
Rufinamide—SCN7A—brain—attention deficit hyperactivity disorder	0.00666	0.0164	CbGeAlD
Rufinamide—SCN2A—midbrain—attention deficit hyperactivity disorder	0.00656	0.0161	CbGeAlD
Rufinamide—SCN9A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00639	0.0108	CbGpPWpGaD
Rufinamide—SCN3A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00611	0.0103	CbGpPWpGaD
Rufinamide—SCN4A—nervous system—attention deficit hyperactivity disorder	0.00609	0.015	CbGeAlD
Rufinamide—SCN8A—brain—attention deficit hyperactivity disorder	0.00594	0.0146	CbGeAlD
Rufinamide—SCN1A—nervous system—attention deficit hyperactivity disorder	0.00587	0.0144	CbGeAlD
Rufinamide—SCN4A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00587	0.0099	CbGpPWpGaD
Rufinamide—SCN2A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00587	0.0099	CbGpPWpGaD
Rufinamide—SCN4A—central nervous system—attention deficit hyperactivity disorder	0.00586	0.0144	CbGeAlD
Rufinamide—SCN3A—midbrain—attention deficit hyperactivity disorder	0.00576	0.0142	CbGeAlD
Rufinamide—SCN1A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00566	0.00955	CbGpPWpGaD
Rufinamide—SCN10A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00566	0.00955	CbGpPWpGaD
Rufinamide—SCN1A—central nervous system—attention deficit hyperactivity disorder	0.00565	0.0139	CbGeAlD
Rufinamide—SCN1A—cerebellum—attention deficit hyperactivity disorder	0.00553	0.0136	CbGeAlD
Rufinamide—CES1—nervous system—attention deficit hyperactivity disorder	0.00544	0.0134	CbGeAlD
Rufinamide—SCN2A—nervous system—attention deficit hyperactivity disorder	0.00539	0.0132	CbGeAlD
Rufinamide—CES1—central nervous system—attention deficit hyperactivity disorder	0.00524	0.0129	CbGeAlD
Rufinamide—SCN9A—brain—attention deficit hyperactivity disorder	0.00522	0.0128	CbGeAlD
Rufinamide—SCN10A—nervous system—attention deficit hyperactivity disorder	0.0052	0.0128	CbGeAlD
Rufinamide—SCN2A—central nervous system—attention deficit hyperactivity disorder	0.00519	0.0127	CbGeAlD
Rufinamide—SCN2A—cerebellum—attention deficit hyperactivity disorder	0.00507	0.0125	CbGeAlD
Rufinamide—SCN10A—central nervous system—attention deficit hyperactivity disorder	0.005	0.0123	CbGeAlD
Rufinamide—GRM5—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0049	0.00825	CbGpPWpGaD
Rufinamide—SCN3A—nervous system—attention deficit hyperactivity disorder	0.00474	0.0116	CbGeAlD
Rufinamide—SCN5A—nervous system—attention deficit hyperactivity disorder	0.00472	0.0116	CbGeAlD
Rufinamide—SCN4A—brain—attention deficit hyperactivity disorder	0.00465	0.0114	CbGeAlD
Rufinamide—SCN3A—central nervous system—attention deficit hyperactivity disorder	0.00456	0.0112	CbGeAlD
Rufinamide—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.00455	0.0112	CbGeAlD
Rufinamide—SCN1A—brain—attention deficit hyperactivity disorder	0.00449	0.011	CbGeAlD
Rufinamide—SCN3A—cerebellum—attention deficit hyperactivity disorder	0.00446	0.011	CbGeAlD
Rufinamide—CES1—brain—attention deficit hyperactivity disorder	0.00416	0.0102	CbGeAlD
Rufinamide—SCN2A—brain—attention deficit hyperactivity disorder	0.00412	0.0101	CbGeAlD
Rufinamide—SCN5A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00398	0.00671	CbGpPWpGaD
Rufinamide—SCN10A—brain—attention deficit hyperactivity disorder	0.00397	0.00976	CbGeAlD
Rufinamide—SCN7A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00366	0.00618	CbGpPWpGaD
Rufinamide—SCN3A—brain—attention deficit hyperactivity disorder	0.00362	0.0089	CbGeAlD
Rufinamide—SCN5A—brain—attention deficit hyperactivity disorder	0.00361	0.00887	CbGeAlD
Rufinamide—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00348	0.00856	CbGeAlD
Rufinamide—GRM5—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00328	0.00554	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00326	0.0055	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00322	0.00542	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00299	0.00503	CbGpPWpGaD
Rufinamide—ALB—brain—attention deficit hyperactivity disorder	0.00289	0.0071	CbGeAlD
Rufinamide—GRM5—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00277	0.00466	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00261	0.00441	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00258	0.00435	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00251	0.00424	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00247	0.00417	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00241	0.00407	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00236	0.00398	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00233	0.00393	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00231	0.00389	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.0023	0.00388	CbGpPWpGaD
Rufinamide—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00224	0.0055	CbGeAlD
Rufinamide—GRM5—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00223	0.00376	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00222	0.00374	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00222	0.00374	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00221	0.00372	CbGpPWpGaD
Rufinamide—GRM5—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.0022	0.00372	CbGpPWpGaD
Rufinamide—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00215	0.00529	CbGeAlD
Rufinamide—SCN1A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00214	0.00361	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00214	0.00361	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00213	0.00359	CbGpPWpGaD
Rufinamide—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.0021	0.00517	CbGeAlD
Rufinamide—SCN8A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.0021	0.00355	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.0021	0.00355	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00197	0.00332	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00195	0.00329	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00192	0.00324	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0019	0.00321	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00186	0.00313	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00184	0.0031	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00182	0.00307	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00181	0.00306	CbGpPWpGaD
Rufinamide—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.0018	0.00442	CbGeAlD
Rufinamide—GRM5—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00175	0.00296	CbGpPWpGaD
Rufinamide—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00173	0.00426	CbGeAlD
Rufinamide—GRM5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00172	0.00291	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00172	0.00291	CbGpPWpGaD
Rufinamide—CYP2E1—brain—attention deficit hyperactivity disorder	0.00171	0.0042	CbGeAlD
Rufinamide—GRM5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0017	0.00287	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.0017	0.00287	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00168	0.00284	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00168	0.00284	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00165	0.00278	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00165	0.00278	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00164	0.00277	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00164	0.00276	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00163	0.00274	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00159	0.00268	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00158	0.00267	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00158	0.00267	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00156	0.00264	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00156	0.00264	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00156	0.00262	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00153	0.00257	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00153	0.00257	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00152	0.00256	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00152	0.00256	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00151	0.00254	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00151	0.00254	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.0015	0.00254	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.0015	0.00253	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0015	0.00253	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00149	0.00251	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00148	0.0025	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00143	0.00241	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00143	0.00241	CbGpPWpGaD
Rufinamide—CES1—E2F transcription factor network—EP300—attention deficit hyperactivity disorder	0.0014	0.00236	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00138	0.00232	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00138	0.00232	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00137	0.00231	CbGpPWpGaD
Rufinamide—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00132	0.00223	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00126	0.00212	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00121	0.00205	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00116	0.00196	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00116	0.00195	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00114	0.00193	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00114	0.00193	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00112	0.00188	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00112	0.00188	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00111	0.00187	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00111	0.00187	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.0011	0.00186	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0011	0.00186	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00108	0.00181	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00108	0.00181	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00107	0.00181	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00106	0.00179	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00106	0.00179	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00102	0.00173	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00102	0.00172	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00102	0.00172	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.001	0.00169	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000995	0.00168	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000992	0.00167	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000984	0.00166	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000984	0.00166	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000976	0.00165	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000975	0.00164	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000975	0.00164	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000969	0.00163	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000963	0.00162	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000956	0.00161	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000933	0.00157	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00093	0.00157	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0009	0.00152	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000897	0.00151	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000885	0.00149	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000874	0.00147	CbGpPWpGaD
Rufinamide—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000874	0.00147	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000814	0.00137	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.000786	0.00133	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000756	0.00128	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000692	0.00117	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000676	0.00114	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000628	0.00106	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000591	0.000996	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00057	0.000962	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000549	0.000926	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000532	0.000897	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000523	0.000882	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000516	0.000871	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000496	0.000836	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000494	0.000833	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000481	0.000811	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000478	0.000807	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000473	0.000798	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000468	0.000789	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000464	0.000783	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000461	0.000778	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000426	0.000719	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000413	0.000697	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000406	0.000684	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000405	0.000684	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00039	0.000658	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00034	0.000573	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000337	0.000568	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000315	0.000532	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000302	0.000509	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00029	0.000489	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00029	0.000489	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000279	0.000471	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000279	0.000471	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000217	0.000366	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000215	0.000363	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000214	0.000361	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000213	0.000359	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000196	0.000331	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000191	0.000322	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000179	0.000301	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000173	0.000291	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000164	0.000277	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000132	0.000223	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000132	0.000223	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00013	0.000219	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000121	0.000204	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000113	0.000191	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000113	0.000191	CbGpPWpGaD
Rufinamide—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000112	0.000188	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000106	0.000178	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000104	0.000175	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.0001	0.000169	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.07e-05	0.000153	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.87e-05	0.00015	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.63e-05	0.000146	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	8e-05	0.000135	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.94e-05	0.000134	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	7.27e-05	0.000123	CbGpPWpGaD
Rufinamide—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	6.87e-05	0.000116	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	6.82e-05	0.000115	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.62e-05	0.000112	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	6.12e-05	0.000103	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.12e-05	0.000103	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	6.02e-05	0.000102	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.6e-05	9.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.9e-05	8.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.66e-05	7.86e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.71e-05	6.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.68e-05	6.21e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.43e-05	5.78e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	2.95e-05	4.97e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.59e-05	2.68e-05	CbGpPWpGaD
